Stories about Patient

Subscribe to Patient

19.01.2021 – 15:01

Sophia Genetics
SOPHiA GENETICS Appoints Influential Regulatory Figure Kathy L. Hibbs to Board of Directors

Boston and Lausanne, Switzerland (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Kathy L. Hibbs was nominated to the company's Board of Directors and its Audit Committee. Hibbs is an accomplished healthcare technology executive, currently holding the position of Chief Legal ...

more
18.01.2021 – 12:00

FDI World Dental Federation

New report from FDI World Dental Federation tackles oral health inequalities and outlines strategies to improve oral healthcare over the next ten years

more
18.01.2021 – 09:00

Debiopharm International SA
PHASE II RESEARCH AGAINST COVID-19 LAUNCHED IN FRANCE WITH DEBIOPHARM’S ANTIVIRAL ALISPORIVIR

Lausanne, Switzerland (ots) - · Pre-clinical in vitro research from the Mondor Institute of Biomedical Research (INSERM U955) has shown evidence for the effectiveness of alisporivir against the replication of SARS-COV-2 (COVID-19).1 · A randomized, investigator-initiated, phase II study, conducted by the AP-HP ...

more
15.01.2021 – 15:15

Semdor Pharma Group

Merger: Newly-formed Semdor Pharma Group becomes one of Europe's leading pharmaceutical companies for narcotics and medical cannabis

more
14.01.2021 – 09:01

Debiopharm International SA
NUCLEAI AND DEBIOPHARM LAUNCH RESEARCH COLLABORATION UTILIZING NUCLEAI’S AI-POWERED BIOMARKER PLATFORM

Tel Aviv, Israel / Lausanne, Switzerland (ots) - Nucleai (www.Nucleaimd.com), a global provider in pathology-based biomarker discovery, and Debiopharm (www.debiopharm.com), a Swiss-based biopharmaceutical company specializing in drug development, announced that they have entered into a long-term collaboration to ...

more
12.01.2021 – 09:00

Grünenthal Group

Florian Dieckmann new VP Global Communications at Grünenthal

more
07.01.2021 – 11:55

nal von minden GmbH
COVID-19: Use rapid tests to identify important biomarkers and predict the course of the disease

Moers (ots) - Whether it’s a lung embolism or a heart attack – an infection with coronavirus can have life-threatening consequences. But how badly will different patients be affected by COVID-19? This can be determined by certain biomarkers. nal von minden GmbH’s biomarker rapid tests from Germany deliver reliable results in just 15 minutes. An infection with ...

more
04.01.2021 – 16:43

CeramTec-Gruppe

CeramTec Group acquires Dentalpoint AG to expand its ceramic Medtech leadership

more
28.12.2020 – 13:55

Technische Universität München
Artificial intelligence improves accuracy: self-learning algorithms analyze medical imaging data

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36399/ High resolution images: https://mediatum.ub.tum.de/1585829 NEWS RELEASE Quick look under the skin Self-learning algorithms analyze medical imaging ...

more
22.12.2020 – 10:52

Technische Universität München
Breathing rate predicts therapeutic benefits for heart patients

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36385/ NEWS RELEASE Discovering a forgotten biosignal Breathing rate predicts therapeutic benefits for heart patients Conditions causing arrhythmia are among ...

more
21.12.2020 – 13:59

Servier
Servier to Acquire Agios Pharmaceuticals' Oncology Business

Paris and Boston (ots/PRNewswire) - - Transaction includes commercial, clinical and research-stage oncology portfolio and employees for up to $2 billion plus royalties - Includes Agios' marketed medicine TIBSOVO® and a strong oncology pipeline of Phase 3 and early-stage assets - Acquisition in-line with Servier's strategic ambition to become a recognized and innovative player in oncology, supported by unique drug ...

more
18.12.2020 – 09:10

Bosch Healthcare Solutions GmbH

Bosch's rapid coronavirus test delivers results for positive samples in less than 30 minutes

more
16.12.2020 – 10:00

Grünenthal Group
Peripheral NOP agonist addressing chronic peripheral neuropathic pain enters clinical development

Aachen (ots) - Grünenthal announced today that the first participants have been enrolled in a Phase I trial of a peripherally restricted Nociceptin/orphanin peptide receptor (NOP) agonist, an oral investigational medicine with a unique mechanism of action for the treatment of chronic peripheral neuropathic pain. The Phase I trial will include 76 healthy participants. ...

more
14.12.2020 – 14:45

Conduent
Conduent Seamless® Transportation System Now Allows Passengers in France's Tours Métropole Urban Area to Use Their Smartphone for Contactless Payments

Guilherand-Granges, France, and Florham Park, N.j. (ots/PRNewswire) - Combined 1.5 million residents in seven urban areas across France can now access public transportation services using the Seamless® Transportation System Conduent Transportation, a unit of business process services and solutions company Conduent ...

more
14.12.2020 – 03:00

Fresenius Kabi Deutschland GmbH
High prevalence of hospital malnutrition associated with poor clinical outcomes

BAD HOMBURG (ots) - Hospital malnutrition is documented in many observational studies from the United States, Europe, and Latin America. A recently published literature review found that malnutrition is highly prevalent across different hospital patient groups in 11 countries in Asia.[1] More than 60 % of the studies included in the analysis found that at least 40 % of ...

more
11.12.2020 – 15:17

Technische Universität München
"The machine as extension of the body"

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 25439 – email: presse@tum.de – web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36357/ High resolution images: https://mediatum.ub.tum.de/1584317 Video: https://youtu.be/Gkjcsvl9WDM NEWS RELEASE Prof. Gordon Cheng on the challenges of fusing robotics and neuroscience “The machine as ...

more
09.12.2020 – 11:51

Stada Arzneimittel
STADA extends ViruProtect partnership with Enzymatica to cover Nordic region

STADA extends ViruProtect partnership with Enzymatica to cover Nordic region - STADA has licensed from Enzymatica rights to market and sell ViruProtect® in Denmark, Finland, Iceland and Norway. - Having recently extended their partnership to cover Russia, Poland, Ukraine and 11 further countries in the ...
One document
more
09.12.2020 – 11:49

Stada Arzneimittel
STADA extends ViruProtect partnership with Enzymatica to cover Nordic region

STADA extends ViruProtect partnership with Enzymatica to cover Nordic region - STADA has licensed from Enzymatica rights to market and sell ViruProtect® in Denmark, Finland, Iceland and Norway. - Having recently extended their partnership to cover Russia, Poland, Ukraine and 11 further countries in the ...
One document
more
08.12.2020 – 15:15

Gerresheimer AG
Gerresheimer: On the path to sustainable profitable growth

Duesseldorf (ots) - - Transformation into a growth value as innovation leader and solution provider - Gerresheimer presents strategy process formula G as an engine towards sustainable profitable growth - Over proportional growth will be achieved by expanding in high value solutions, digital applications and growth regions - Strategic investments in growth ...
One document
more
08.12.2020 – 14:26

Syntellix AG
Frost & Sullivan honours Syntellix with 2020 Best Practices Award, names Syntellix "European Entrepreneurial Company of the Year"

Hanover (ots) - Internationally renowned and globally leading market research firm Frost & Sullivan presents Syntellix with this year's Best Practices Entrepreneurial Company of the Year Award in the European orthopaedic and trauma implants industry. The title was awarded after a rigorous analytical process that ...

more
08.12.2020 – 14:00

Novaliq GmbH
Novaliq Announces First Patient Randomized in the Phase 3 trial ESSENCE-2 of CyclASol® Topical Ophthalmic Solution for the Treatment of Dry Eye Disease

Heidelberg, Germany (ots/PRNewswire) - - ESSENCE-2 is the second registration trial to complete the clinical development of CyclASol® as agreed with U.S. Food and Drug Administration (FDA) - Designed to replicate efficacy demonstrated in previous phase 2/3 ESSENCE-1 trial - Topline data expected in 2nd half 2021 ...

more
07.12.2020 – 09:00

SIFI Press & Communication Office
SIFI appoints Jelle Kleijn as Global Head of Acanthamoeba Keratitis to globally lead the effort to deliver the first registered treatment for this rare sight-threatening parasitic eye infection

Catania, Italy (ots/PRNewswire) - Given urgency to treat, SIFI has established a dedicated cross-functional team to accelerate the launch of polihexanide monotherapy in Europe and the United States. SIFI, a leading ophthalmic company, is pleased to announce the recent appointment of Jelle Kleijn, PhD, as Global Head ...

more
05.12.2020 – 16:00

Sysmex Inostics GmbH
Sysmex Inostics Presents Data at the American Society of Hematology Annual Meeting Demonstrating Exquisite Sensitivity of SafeSEQ NGS Technology for Detection of Measurable Residual Disease in Acute Myeloid Leukemia

Baltimore, MD (ots) - Sysmex Inostics, Inc., a global leader and pioneer in blood-based, high-sensitivity molecular testing for oncology, is presenting the poster "Ultrasensitive Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML) Using a Targeted Next Generation Sequencing (NGS) Panel" at ...

more
03.12.2020 – 11:48

nal von minden GmbH

New study: Only reliable rapid corona tests make sense

more
02.12.2020 – 13:00

BD (Becton, Dickinson and Company)
BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years

Franklin Lakes, N.j. (ots/PRNewswire) - - Investment includes new manufacturing facility in Europe BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and ...

more
01.12.2020 – 09:12

Grünenthal Group
Grünenthal agrees to acquire European rights to CRESTOR [TM] (rosuvastatin) from AstraZeneca

Aachen, Germany (ots) - Grünenthal, a global science-based, privately-owned pharmaceutical company, today announced that it has agreed to acquire the European rights (excluding Spain and the UK) to CRESTOR[TM] (rosuvastatin) and its associated brands for a total consideration of up to US$ 350 million. CRESTOR(TM) is among the leading statin products in Europe and is ...

more
01.12.2020 – 09:00

Norgine
Norgine B.V. Announces New European Healthcare Subsidiary To Strengthen Its Consumer Healthcare Portfolio

Amsterdam, The Netherlands (ots/PRNewswire) - Norgine B.V. ("Norgine"), today announced the establishment of a wholly-owned subsidiary, Norgine Healthcare B.V. ("Norgine Healthcare"), which will be dedicated to consumer healthcare. To view the Multimedia News Release, please click: ...

more
26.11.2020 – 17:37

Merck KGaA
European Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations

Darmstadt, Germany (ots/PRNewswire) - Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial ...

more
23.11.2020 – 12:55

Fördergesellschaft IZB mbH

5
Commemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-ups

In the IZB you can find over 50 biotech start-ups
One document
more
23.11.2020 – 12:00

Fresenius Kabi Deutschland GmbH
Fresenius Kabi and ASPEN partner for an expert interview series on omega-3 fatty acid containing parenteral nutrition

BAD HOMBURG (ots) - Evidence indicates that omega-3 (?-3) fatty acid containing parenteral nutrition (PN) improves clinical outcomes compared with standard PN in adult patients,1 underlining its role in today's hospitals and clinics. To support continuous health care professional (HCP) education on omega-3 fatty ...

more

12345678910Next